CR5959A - Tratamiento para la disfuncion sexual femenina - Google Patents

Tratamiento para la disfuncion sexual femenina

Info

Publication number
CR5959A
CR5959A CR5959A CR5959A CR5959A CR 5959 A CR5959 A CR 5959A CR 5959 A CR5959 A CR 5959A CR 5959 A CR5959 A CR 5959A CR 5959 A CR5959 A CR 5959A
Authority
CR
Costa Rica
Prior art keywords
apomorphine
treatment
sexual dysfunction
female sexual
clitoris
Prior art date
Application number
CR5959A
Other languages
English (en)
Inventor
El-Rashidy Ragab
Ronsen Bruce
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of CR5959A publication Critical patent/CR5959A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA DISFUNSION SEXUAL EN LA MUJER PUEDE SER AMINORADA, SIN EFECTOS SECUNDARIOS SUBSTANCIALES INDESEABLES POR LA ADMINISTRACION SUBLINGUAL DE DOSIS DE APOMORFINA. LA ADMINISTRACION DE APOMORFINA INCREMENTA LA ESTIMULACION DEL CLITORIS MEDIANTE EL FLUJO DE LA SANGRE INTRACAVERNOSAL Y EL FLUJO DE SANGRE EN LAS PAREDES DE LA VAGINA PARA OBTENER LA ERECCION DEL CLITORIS Y EL CONGESTIONAMIENTO VAGINAL DE LA MUJER. LA CONCENTRACION DE PLASMA DE APOMORFINA DE NO MAS DE 5.5 MANOGRAMOS POR MILILITRO ES PREFERIBLEMENTE MANTENIDA.
CR5959A 1998-01-30 1999-01-28 Tratamiento para la disfuncion sexual femenina CR5959A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/016,252 US5945117A (en) 1998-01-30 1998-01-30 Treatment of female sexual dysfunction

Publications (1)

Publication Number Publication Date
CR5959A true CR5959A (es) 1999-07-28

Family

ID=21776169

Family Applications (1)

Application Number Title Priority Date Filing Date
CR5959A CR5959A (es) 1998-01-30 1999-01-28 Tratamiento para la disfuncion sexual femenina

Country Status (34)

Country Link
US (2) US5945117A (es)
EP (1) EP1056419A4 (es)
JP (1) JP2002501875A (es)
KR (1) KR20010040477A (es)
CN (1) CN1250221C (es)
AR (1) AR017976A1 (es)
AU (1) AU752928B2 (es)
BG (1) BG64667B1 (es)
BR (1) BR9908038A (es)
CA (1) CA2322289A1 (es)
CO (1) CO4970819A1 (es)
CR (1) CR5959A (es)
DZ (1) DZ2714A1 (es)
GC (1) GC0000096A (es)
GT (1) GT199900013A (es)
HK (1) HK1040901B (es)
HN (1) HN1999000015A (es)
HU (1) HUP0101268A3 (es)
IL (2) IL137569A0 (es)
JO (1) JO2085B1 (es)
MA (1) MA26600A1 (es)
MX (1) MXPA00007447A (es)
NO (1) NO319821B1 (es)
NZ (1) NZ506597A (es)
PA (1) PA8467801A1 (es)
PE (1) PE20000240A1 (es)
PL (1) PL194350B1 (es)
SK (1) SK11362000A3 (es)
TN (1) TNSN99008A1 (es)
TR (1) TR200002220T2 (es)
TW (1) TW550069B (es)
UY (1) UY25374A1 (es)
WO (1) WO1999038467A1 (es)
ZA (1) ZA99686B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20020165122A1 (en) * 1994-04-22 2002-11-07 Heaton Jeremy P. W. Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
CA2334550A1 (en) * 1998-06-22 1999-12-29 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050245494A1 (en) * 1999-07-01 2005-11-03 40 J's Llc Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20050070499A1 (en) * 1999-11-08 2005-03-31 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
JP2003532640A (ja) * 2000-04-07 2003-11-05 タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド アポモルヒネ誘導体及びその使用方法
AU2001261244B2 (en) 2000-05-09 2006-08-03 Nitromed, Inc. Infrared thermography and methods of use
ES2291333T3 (es) * 2000-06-27 2008-03-01 Qualilife Pharmaceuticals Inc. Composiciones y metodos para el tratamiento de la respuesta sexual de las mujeres.
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
WO2002007757A2 (en) * 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
MXPA03004288A (es) 2000-11-15 2004-09-10 Tap Pharmaceutical Prod Inc Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina.
AU2002226895B2 (en) * 2000-11-22 2006-10-12 Abbott Laboratories Selective dopamine D4 receptor agonists for treating sexual dysfunction
NZ527113A (en) * 2001-02-08 2005-04-29 Pharmacia Corp Rapid-onset medicament for the treatment of sexual dysfunction
US20060004190A1 (en) * 2002-03-19 2006-01-05 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
US20040138291A1 (en) * 2002-10-10 2004-07-15 Adams Michael A. Treatment of sexual dysfunction
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
JP2006522785A (ja) * 2003-04-14 2006-10-05 ベクトゥラ・リミテッド アポモルヒネを含む肺吸入用医薬組成物
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
CA2564994A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
WO2006100557A1 (en) * 2005-03-21 2006-09-28 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
WO2006100588A1 (en) * 2005-03-21 2006-09-28 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
JP5256425B2 (ja) * 2005-04-08 2013-08-07 リングアル コンセグナ ピーティーワイ エルティーディー 口腔送達システム
JP2009504628A (ja) * 2005-08-10 2009-02-05 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
US8349850B2 (en) * 2006-03-28 2013-01-08 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US7800094B2 (en) * 2007-06-11 2010-09-21 Macronix International Co., Ltd. Resistance memory with tungsten compound and manufacturing
KR102017009B1 (ko) * 2009-06-12 2019-09-02 선오비온 파마슈티컬스 인코포레이티드 설하 아포모르핀
WO2011130608A1 (en) * 2010-04-15 2011-10-20 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
KR101890317B1 (ko) 2010-12-16 2018-08-22 선오비온 파마슈티컬스 인코포레이티드 설하 필름
EP3581567A1 (en) 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2545905A1 (en) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited A new therapeutical composition containing apomorphine as active ingredient
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
JPH07506823A (ja) * 1992-05-18 1995-07-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 記憶障害，性的機能不全およびパーキンソン氏病の治療のためのインドロン誘導体の使用
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
CA2188385C (en) * 1994-04-22 2000-07-11 Ragab El-Rashidy Dosage forms and method for ameliorating male erectile dysfunction
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
BG104715A (bg) 2001-02-28
CA2322289A1 (en) 1999-08-05
EP1056419A4 (en) 2007-05-02
JO2085B1 (en) 2000-05-21
HUP0101268A2 (hu) 2001-09-28
TR200002220T2 (tr) 2000-12-21
AU752928B2 (en) 2002-10-03
AR017976A1 (es) 2001-10-24
US6193992B1 (en) 2001-02-27
NZ506597A (en) 2003-07-25
NO20003845D0 (no) 2000-07-27
PL194350B1 (pl) 2007-05-31
AU2564499A (en) 1999-08-16
IL137569A (en) 2006-08-01
IL137569A0 (en) 2001-07-24
SK11362000A3 (sk) 2001-02-12
GT199900013A (es) 2001-07-20
HN1999000015A (es) 1999-08-23
TNSN99008A1 (fr) 2005-11-10
CN1250221C (zh) 2006-04-12
UY25374A1 (es) 1999-09-27
BG64667B1 (bg) 2005-11-30
US5945117A (en) 1999-08-31
TW550069B (en) 2003-09-01
ZA99686B (en) 1999-07-28
DZ2714A1 (fr) 2003-09-01
PL342062A1 (en) 2001-05-21
HK1040901B (zh) 2006-11-24
JP2002501875A (ja) 2002-01-22
PA8467801A1 (es) 2000-09-29
NO319821B1 (no) 2005-09-19
NO20003845L (no) 2000-09-28
CN1313742A (zh) 2001-09-19
BR9908038A (pt) 2002-01-02
MA26600A1 (fr) 2004-12-20
HUP0101268A3 (en) 2002-12-28
MXPA00007447A (es) 2006-01-25
CO4970819A1 (es) 2000-11-07
GC0000096A (en) 2005-06-29
EP1056419A1 (en) 2000-12-06
HK1040901A1 (en) 2002-06-28
PE20000240A1 (es) 2000-03-31
KR20010040477A (ko) 2001-05-15
WO1999038467A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
CR5959A (es) Tratamiento para la disfuncion sexual femenina
US5891915A (en) Method for enhancing female sexual response and an ointment therefor
HUP0004347A2 (hu) Vegyületek női szexuális diszfunkció kezelésére
EA199700213A1 (ru) Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
DE60128540D1 (de) Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen
ATE233091T1 (de) Verwendung von histamine-2 agonisten zur behandlung sexueller funktionsstörungen
NZ517038A (en) Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
ITMI922331A1 (it) Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
ATE289293T1 (de) Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons
ATE252910T1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
RU2002104498A (ru) Применение тозилхлорамидов для лечения заболеваний кожи, слизистой оболочки, органов и тканей
US20080213407A1 (en) Topical application of L-arginine and menthol to increase penis size
AR019694A1 (es) Metodo para el tratamiento o reduccion de la disfuncion sexual femenina.
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
ECSP992843A (es) Procedimiento para aminorar la disfuncion sexual femenina
RU2224562C2 (ru) Способ лечения хронического простатита
RU2234330C2 (ru) Способ лечения больных эректильной дисфункцией
TH65931A3 (th) ยาสำหรับหญิงที่เสื่อมสมรรถภาพทางเพศและวิธีการใช้
RU2082468C1 (ru) Способ лечения больных, страдающих краурозом вульвы
محمد أكرم رنداوا et al. A Review of the Developmental, Structural, Biochemical, Pathophysiological and Pharmacological Similarities between Male and Female Genitals
RU2529812C2 (ru) Биологически активная композиция
RU2048808C1 (ru) Средство, стимулирующее потенцию
Korda et al. The female prostate and female ejaculation is known since the 11th century
McCaffrey et al. The history of hysteria and the evolution of the management of female sexual dysfunction
Hatzinger et al. CASTRATOS-EVERYTHING FOR FAME

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)